Cystic fibrosis as a modulable model for host – microorganism interactions in airway disease.

Cystic fibrosis as a modulable model for host - microorganism interactions in airway disease.

Influence of CFTR modulator therapy on microbial behaviour in cystic fibrosis

ABPA Crystal Clear project: Charcot-Leyden crystals and galectin-10 as a potential diagnostic marker and therapeutic target in allergic bronchopulmonary aspergillose (ABPA) in patients with cystic fibrosis

BOF-TT-professorship in respiratory infectious diseases and cystic fibrosis

Cystic fibrosis as a modulable model for mucosal and systemic immunity in airway disease.

Cystic fibrosis as a modulable model for mucosal and systemic immunity in airway disease.

King Baudouin Foundation - Fund Alphonse and Jean Forton and Belgian Cystic Fibrosis Society: "Modulation of host - microorganism interactions in cystic fibrosis: the CF Model study"

King Baudouin Foundation - Fund Alphonse and Jean Forton and the Belgian CF Association: "Charcot-Leyden crystals and Galectin-10 as potential diagnostic and therapeutic target in cystic fibrosis-associated allergic bronchopulmonary aspergillosis (ABPA)"

UNRAVELING HOST–PATHOGEN INTERACTIONS IN LUNG DISEASE: THE CYSTIC FIBROSIS LUNG AS AN INFLAMMATORY MICROENVIRONMENT MODEL

A MESO QuickPlex SQ system to measure single or multiple immunotargets in biofluids

An integrated approach to unravel eosinophil function in chronic eosinophilic disorders

BOF-TT-professorship in respiratory infectious diseases and cystic fibrosis

ClinicalTrials.COV : Clinical long term-follow up of COVID-19 patients that underwent immuneintervention clinical trials or standard of care.